Lv1
60 积分 2026-03-12 加入
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
16小时前
待确认
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
17小时前
已完结
LBA66 Ensartinib as adjuvant therapy in patients (pts) with stage IB–IIIB ALK-positive (ALK+) non-small cell lung cancer (NSCLC) after complete tumor resection: The phase III randomized ELEVATE trial
3天前
求助中
Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer
10天前
已完结
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study
10天前
已完结
The effect of liver metastasis on efficacy of immunotherapy plus chemotherapy in advanced lung cancer
10天前
已完结
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
1个月前
已完结
Radiomics Biomarkers to Predict Checkpoint Inhibitor Pneumonitis in Non-small Cell Lung Cancer
1个月前
已完结
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1个月前
已完结
The relationship of fatigue in breast cancer survivors with quality of life and factors to address in psychological interventions: A systematic review
1个月前
已完结
皖公网安备34019202002308
